Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Tranexamic Acid × Dermatologic × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Sarcoma 2 Head & Neck 2 CNS 2 Tumor-Agnostic 1 Genitourinary 1 Dermatologic 1

Conditions

Recurrence 1 Neoplasms 1 Melanoma 1

Interventions

Dacarbazine 22 Nivolumab 21 pembrolizumab 16 Ipilimumab 16 3-ingenyl angelate 11 Interferon-alpha 10 Imiquimod 10 trametinib 7 aldesleukin 7 Temozolomide 7 dabrafenib 6 cemiplimab 6 Vemurafenib 6 Radiotherapy 6 Introns 6 Interferon alpha-2 6 Fluorouracil 6 methyl 5-aminolevulinate 5 Surgical Procedures, Operative 5 Photochemotherapy 5 Melphalan 5 Interleukin-2 5 Cisplatin 5 Aminolevulinic Acid 5 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Gels 4 Diclofenac 4 Chemotherapy, Adjuvant 4 cobimetinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05899465 2025-03-18

PRIME

University of Aarhus

Phase 3 Recruiting

Melanoma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡